DXCM
Dexcom
October 21, 2026 · intraday
- Rarity
- 1.64
- Peak move
- −6.61%
- Float cap
- $32.4B
Still running — rarity and peak move can only rise from here.
Dexcom designs and sells continuous glucose monitoring (CGM) systems — a wearable sensor, transmitter and receiver/app — that track glucose levels in real time for people with type 1 and type 2 diabetes, as well as for prediabetic and non-insulin users through its over-the-counter Stelo product. It sells to patients, caregivers, clinicians, and health plans, largely in the United States with growing international sales.
Where do you see this going?
no votes yetVote to see the split.
What we found
no events · 0 from SEC or newswire · 0 timed with the moveNothing found.We searched SEC filings, the newswires and the open web across the three days around this move and found no public information that explains it.